中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
2026-09-07
UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR OVERWEIGHT OR OBESITY IN CHINA
Learn More
2026-09-07
Significant Progress in Innovative Drug R&D and Continued Globalization Efforts Profit Attributable to Owners of the Company Reached Approximately RMB347.6 Million
Learn More
2026-08-12
FDA APPROVAL OF IND FOR THE GROUP’S PRODUCT UBT48128 TABLETS
Learn More
2026-07-15
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION
Learn More
2026-07-03
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT TADALAFIL TABLETS
Learn More
All News
Select Year
2026
2025
2024
The 10th anniversary celebration of The United Animal Healthcare (Inner Mongolia) Co., Ltd. along with the launch ceremony of Enrofloxacin and the 8th International Forum on Clinical Applications and Prospects of Veterinary Beta-Lactamase Inhibitors, was held
2025-10-20
The three core production lines of Lianmu Veterinary Pharmaceutical Company passed the GMP on-site acceptance.
2025-10-20
TUL won two awards at the 7th China Pharmaceutical Industry Expo (CMC-CHINA 2025), namely \"2025 Top 30 Active Pharmaceutical Ingredients Business\" and \"2025 Top 101 China Pharmaceutical Industry\"
2025-10-20
THE GROUP’S PRODUCT AMOXICILLIN SODIUMAND CLAVULANATE POTASSIUM FOR INJECTIONPASSED THE CONSISTENCY EVALUATION
2025-10-20
The launch ceremony of the self-made dilute acid and dilute alkali project of The United Laboratories (Inner Mongolia) Co., Ltd.was grandly held
2025-10-20
At the 2025 (42nd) National Pharmaceutical Industry Information Conference, the top 100 enterprises in China's pharmaceutical industry main business revenue for 2024 were announced,with Zhuhai United Laboratories Co., Ltd. ranking 23rd.
2025-10-20
FDA APPROVAL OF IND FOR UBT37034 INJECTION
2025-10-20
TUL showcased its new products at CPHI China 2025 and won two major awards
2025-07-09
Seminar on deepening e-commerce cooperation between TUL and JD Health was successfully held at Zhuhai United Laboratories Co., Ltd.
2025-07-09
Prev
1
...
6
7
8
9
10
...
17
Next
WeChat
Official
Account
To Top
粤公网安备44040402000348号
